Avanir Pharmaceuticals (NASDAQ:AVNR)

Headlines for Avanir Pharmaceuticals

AVANIR Pharmaceuticals Invites Investors to Fourth Quarter and Fiscal Year End Conference Call
RTT News - Nov 17, 2009
ALISO VIEJO, Calif. --(BUSINESS WIRE)-- AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that it will release unaudited financial results for the quarter and fiscal year ended September ...
CORRECT(11/10): Neurological Drug Meets Goal In Extended Trial
Capital.gr - Nov 12, 2009
("Avanir Pharma: Neurological Drug Meets Goal In Extended Trial," published at 9 am EST on Tuesday, omitted that the data also included patients with ALS. A corrected story follows.) Avanir ...
Bank of America, BZH, TYC, JASO, PCLN, EXPE, HEW, AVNR Popular Stocks
Ub News - Nov 10, 2009
US stocks traded lower Tuesday as the Dow Jones Industrial Average fell 13 points to 10214, the S&P 500 declined 3 points to 1090 and the Nasdaq Composite decreased 7 points to 2147. Bank of ...
Pre-Market Round-Up for November 10, 2009
Sumfolio.com - Nov 10, 2009
AVANIR Pharmaceuticals (AVNR), Zhongpin Inc. (HOGS), and China Natural Gas, Inc. (CHNG) are three story stocks to watch as the market is set to open lower. AVANIR Pharmaceuticals [[AVNR]] – Shares ...
Avanir Pharma: Neurological Drug Meets Goal In Extended Trial
Wall Street Journal - Nov 10, 2009
Avanir Pharmaceuticals Inc. (AVNR) said the new low-dose version of neurological disorder pill Zenvia reduced the frequency and severity of uncontrollable emotional outbursts in patients with ...
UPDATE 1-Avanir posts positive Zenvia data, shares rise - Reuters
AVANIR to Present at the Lazard Healthcare Conference - Business Wire
WELT ONLINE - News-Medical.net